ILIUM OPTIGEN EYE OINTMENT

País: Austrália

Língua: inglês

Origem: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes ativos:

GENTAMICIN AS GENTAMICIN SULFATE

Disponível em:

TROY LABORATORIES PTY LTD

DCI (Denominação Comum Internacional):

gentamicin as sulfate(3mg/g)

Forma farmacêutica:

MISC. AURAL, OPHTHALMIC, ORO/NASO PHARYNGEAL

Composição:

GENTAMICIN AS GENTAMICIN SULFATE ANTIBIOTIC Active 3.0 mg/g

Unidades em pacote:

5g

Classe:

VM - Veterinary Medicine

Fabricado por:

TROY LABORATORIES

Grupo terapêutico:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Área terapêutica:

OPHTHALMIC PREPARATIONS

Indicações terapêuticas:

ANTI-INFECTIVE OR ANTISEPTIC | BACTERIAL INFECTIONS | CONJUNCTIVITIS | EYE INFECTIONS | EYE-WASHES | KERATOCONJUNCTIVITIS | OCULAR INFECTIONS

Resumo do produto:

Poison schedule: 4; Withholding period: WHP: NOT APPLICABLE; Host/pest details: CAT: [ANTI-INFECTIVE OR ANTISEPTIC]; DOG: [ANTI-INFECTIVE OR ANTISEPTIC]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ANTI-INFECTIVE OR ANTISEPTIC]; DOG: [ANTI-INFECTIVE OR ANTISEPTIC]; Topical treatment of conjunctivitis in dogs and cats.Not to be used in food producing species of animals. This product should be reserved for the treatment of infections with pathogens of known sensitivity and for use in severe infections for which there is no suitable alternative.

Status de autorização:

Registered

Data de autorização:

2023-07-01

Folheto informativo - Bula

_Main panel_
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ILIUM
OPTIGEN
EYE OINTMENT
ACTIVE CONSTITUENTS:
3
mg/g
GENTAMICIN
as GENTAMICIN SULFATE
Topical treatment of conjunctivitis in dogs and cats
_Ancillary panel_
5 g N E T
ILIUM
DIRECTIONS FOR USE:
NOT TO BE USED IN FOOD PRODUCING SPECIES OF ANIMALS.
THIS PRODUCT SHOULD BE RESERVED FOR THE TREATMENT OF
INFECTIONS WITH PATHOGENS OF KNOWN SENSITIVITY AND FOR USE
IN
SEVERE
INFECTIONS
FOR
WHICH
THERE
IS
NO
SUITABLE
ALTERNATIVE.
DOGS AND CATS: Instill approximately 1 cm strip into the conjunctival
l
sac two
to four times daily.
TROY LABORATORIES PTY. LIMITED
98 LONG ST. SMITHFIELD NSW 2164 AUSTRALIA
Dispose of empty container by wrapping with paper and putting in the
garbage.
Store below 30°C (Room Temperature).
NRA Approval No.:
3 8 6 3 4 / 0 4 9 8
(B)
&
Expiry Date -- see crimp
_plst_
_ label _
_-_
_ 18 March 1998_
_Page 1 of 1_

Características técnicas

MATERIAL SAFETY DATA SHEET
PRODUCT NAME: ILIUM OPTIGEN EYE OINTMENT
PAGE: 1 OF 4
THIS REVISION ISSUED: JULY, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Troy Laboratories Australia Pty Ltd
Phone: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
TROY LABORATORIES AUSTRALIA PTY. LTD ABN: 21 000 283 769
TEL:
[phone]
31-35 GLENDENNING ROAD
FAX:
[phone]
GLENDENNING NSW 2761
CHEMICAL NATURE:
Gentamicin is an antibiotic.
TRADE NAME:
ILIUM OPTIGEN EYE OINTMENT
PRODUCT CODE:
3535
PRODUCT USE:
For the treatment of conjunctivitis in dogs and cats.
CREATION DATE:
AUGUST, 2005
THIS VERSION ISSUED:
JULY, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Light yellow very greasy ointment mass.
ODOUR:
Mild odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. A
significant ingredient is an
antibiotic. Any person with a history of allergies to this class of
substances should avoid all contact with this product
as it may cause sensitisation.
POTENTIAL HEALTH EFFECTS
This is a pharmacologically active preparation, and contact should be
avoided except in actual use. If you have come
into contact with this product, seek medical attention if you feel
drowsy or experience any unusual symptoms.
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that
this product is not harmful. However product may be